Terazosin

NDC 27241-289 · Ajanta Pharma USA Inc.

Generic nameTerazosin

Dosage formCAPSULE

RouteORAL

Active ingredient(s)TERAZOSIN HYDROCHLORIDE

Strength2 mg/1

Pharmacologic classAdrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]

Marketing categoryANDA

Packages

27241-289-01 — 100 CAPSULE in 1 BOTTLE (27241-289-01)

27241-289-10 — 1000 CAPSULE in 1 BOTTLE (27241-289-10)

FDA lists these products with the same active ingredient.

23155-735 — terazosin, 23155-736 — terazosin, 23155-737 — terazosin, 23155-738 — terazosin, 24689-001 — terazosin hydrochloride, 24689-002 — terazosin hydrochloride, 24689-003 — terazosin hydrochloride, 24689-004 — terazosin hydrochloride, 27241-288 — Terazosin, 27241-290 — Terazosin, 27241-291 — Terazosin, 42291-820 — Terazosin Hydrochloride, 42291-821 — Terazosin Hydrochloride, 42291-822 — Terazosin Hydrochloride, 42291-823 — Terazosin Hydrochloride, 50090-0657 — Terazosin Hydrochloride, 50090-2371 — Terazosin Hydrochloride, 50090-2623 — Terazosin Hydrochloride, 50090-7851 — terazosin, 50268-764 — Terazosin Hydrochloride, +62 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.